Nombre de documents


CV de Jean-Christophe Olivier

Article dans une revue5 documents

  • Julien Brillault, Frédéric Tewes, William Couet, Jean-Christophe Olivier. In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.. European Journal of Pharmaceutical Sciences, Elsevier, 2016, 97, pp.92-98. <10.1016/j.ejps.2016.11.011>. <inserm-01416565>
  • Frederic Tewes, Julien Brillault, Barbara Lamy, Peter O 'Connell, Jean-Christophe Olivier, et al.. Ciprofloxacin-Loaded Inorganic–Organic Composite Microparticles To Treat Bacterial Lung Infection. Molecular Pharmaceutics, American Chemical Society, 2015, 13 ((1)), pp.100-12. <10.1021/acs.molpharmaceut.5b00543>. <inserm-01373710>
  • Julien Brillault, Whocely Victor De Castro, Thomas Harnois, Alain Kitzis, Jean Christophe Olivier, et al.. P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3 Lung Epithelial Cell Model. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2009, 53 (4), pp.1457-1462. <10.1128/AAC.01253-08>. <hal-00456585>
  • Frédéric Tewes, Julien Brillault, William Couet, Jean-Christophe Olivier. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.. Journal of Controlled Release, Elsevier, 2008, 129 (2), pp.93-9. <10.1016/j.jconrel.2008.04.007>. <inserm-00319517>
  • Jean-Christophe Olivier, Laurence Fenart, Romain Chauvet, Claudine Pariat, Roméo Cecchelli, et al.. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharmaceutical Research / Pharmaceutical Research (Dordrecht), 1999, 16 (12), p. 1836-1842. <hal-00534822>